Cyclophosphamide, Fludarabine, and Rituximab

About

Membership operator: AND

Therapies: 3

Therapies

Cyclophosphamide (tx:ncit:C405)

Fludarabine (tx:ncit:C1094)

Rituximab (tx:ncit:C1702)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) CD20 + Chronic Lymphocytic Leukemia Cyclophosphamide, Fludarabine, Rituximab